On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, sending its price more than 9% higher at the ...

From the moment the first rate cut occurred, long-term interest rates ... “You know, I want to own, I want to own CRISPR because I keep seeing their name come up and all the science papers ...

Using CRISPR technology, scientists uncovered genes that control C-A-G genetic stumbles in Huntington's disease ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

In a groundbreaking study, scientists from China have successfully created mice with two biological fathers. Though the ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Recent scientific discoveries include the identification of an ancient Antarctic bird as the oldest 'modern' bird, revelations about moon canyons formed by asteroid impact, Chile's struggle with light ...

Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and accident investigation, at Cranfield University. Crispr designed gene cutting ...

StockNews.com raised shares of CRISPR Therapeutics to a “sell” rating in a report on Monday, December 30th. Barclays cut their price target on shares of CRISPR Therapeutics from $59.00 to $55. ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ ... He pointed out that ever since the Federal Reserve began cutting short-term rates in September 2024 ...